FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sumatriptan (Imitrex) Nasal Spray
Status: Resolved
»Duration of Shortage: 11/20/2015 - 02/10/2017
»Therapeutic Categories: Neurology

Expand all

GlaxoSmithKline (Revised 02/10/2017)

Company Contact Information:
888-825-5249

Presentation
  • Sumatriptan (Imitrex®) Nasal Spray, 20 mg (6 doses per device) (NDC 0173-0523-00)
  • Sumatriptan (Imitrex®) Nasal Spray, 5 mg (6 doses per device) (NDC 0173-0524-00)
  • Sumatriptan Nasal Spray, 20 mg 6 doses per device) (NDC 0781-6523-86)
  • Sumatriptan Nasal Spray, 5 mg (6 doses per device) (NDC 0781-6524-86)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English